Keith Hinton
Stock Analyst at Freedom Capital Markets
(2.49)
# 3,006
Out of 5,090 analysts
21
Total ratings
53.8%
Success rate
5.1%
Average return
Main Sectors:
Stocks Rated by Keith Hinton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MMSI Merit Medical Systems | Initiated: Hold | $90 | $92.21 | -2.40% | 1 | Oct 29, 2026 | |
| ATRC AtriCure | Downgraded: Hold | $43 → $57 | $61.42 | -7.20% | 2 | Oct 2, 2026 | |
| CBRS Cerebras Systems | Upgraded: Buy | $209 | $112.56 | +85.68% | 1 | Oct 2, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Buy | $62 → $97 | $70.97 | +36.68% | 2 | Sep 21, 2026 | |
| VCYT Veracyte | Reiterated: Buy | $45 → $66 | $50.31 | +31.19% | 2 | Sep 15, 2026 | |
| PLSE Pulse Biosciences | Initiated Coverage: Buy | $73 | $53.67 | +36.02% | 1 | Sep 9, 2026 | |
| ENOV Enovis | Reiterated: Buy | $45 → $36 | $21.91 | +64.31% | 2 | Sep 1, 2026 | |
| GMED Globus Medical | Reiterated: Hold | $87 | $81.26 | +7.06% | 2 | Aug 27, 2026 | |
| LIVN LivaNova | Reiterated: Hold | $81 → $75 | $80.66 | -7.02% | 2 | Aug 20, 2026 | |
| LMAT LeMaitre Vascular | Reiterated: Hold | $81 | $82.87 | -2.26% | 1 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $17 | $11.45 | +48.47% | 2 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $102 | $64.69 | +57.68% | 1 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $112 → $127 | $126.55 | +0.36% | 2 | Aug 4, 2026 |
Merit Medical Systems
Oct 29, 2026
Initiated: Hold
Price Target: $90
Current: $92.21
Upside: -2.40%
AtriCure
Oct 2, 2026
Downgraded: Hold
Price Target: $43 → $57
Current: $61.42
Upside: -7.20%
Cerebras Systems
Oct 2, 2026
Upgraded: Buy
Price Target: $209
Current: $112.56
Upside: +85.68%
Inspire Medical Systems
Sep 21, 2026
Reiterated: Buy
Price Target: $62 → $97
Current: $70.97
Upside: +36.68%
Veracyte
Sep 15, 2026
Reiterated: Buy
Price Target: $45 → $66
Current: $50.31
Upside: +31.19%
Pulse Biosciences
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $73
Current: $53.67
Upside: +36.02%
Enovis
Sep 1, 2026
Reiterated: Buy
Price Target: $45 → $36
Current: $21.91
Upside: +64.31%
Globus Medical
Aug 27, 2026
Reiterated: Hold
Price Target: $87
Current: $81.26
Upside: +7.06%
LivaNova
Aug 20, 2026
Reiterated: Hold
Price Target: $81 → $75
Current: $80.66
Upside: -7.02%
LeMaitre Vascular
Aug 14, 2026
Reiterated: Hold
Price Target: $81
Current: $82.87
Upside: -2.26%
Aug 12, 2026
Reiterated: Buy
Price Target: $25 → $17
Current: $11.45
Upside: +48.47%
Aug 11, 2026
Reiterated: Buy
Price Target: $102
Current: $64.69
Upside: +57.68%
Aug 4, 2026
Downgraded: Hold
Price Target: $112 → $127
Current: $126.55
Upside: +0.36%